• Exchange: Continuous
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

GRF:SM

35.4950 EUR 0.1050 0.29%

As of 11:38:00 ET on 08/28/2014.

Snapshot for Grifols SA (GRF)

Open: 35.6000 Day's Range: 35.4250 - 35.7800 Volume: 772,416
Previous Close: 35.6000 52wk Range: 28.2500 - 42.5300 1-Yr Rtn: +17.39%

Stock Chart for GRF

No chart data available.
  • GRF:SM 35.4900
  • 1D
  • 1M
  • 1Y
35.6000
Interactive GRF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for GRF

Current P/E Ratio (ttm) 31.5788
Estimated P/E(12/2014) 20.5649
Relative P/E vs. IBEX 1.4897
Earnings Per Share (EUR) (ttm) 1.1240
Est. EPS (EUR) (12/2014) 1.7260
Est. PEG Ratio 1.1702
Market Cap (M EUR) 11,500.45
Shares Outstanding (M) 213.06
30 Day Average Volume 1,187,642
Price/Book (mrq) 5.4680
Price/Sale (ttm) 4.0747
Dividend Indicated Gross Yield 0.57%
Cash Dividend (EUR) 0.1585
Dividend Ex-Date 06/05/2014
5 Year Dividend Growth -1.58%
Next Earnings Announcement 11/05/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for GRF

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for GRF

Grifols S.A. develops, manufactures, and markets plasma derivatives, IV Therapy, Enteral nutrition, diagnostic systems, and medical materials.

Victor Grifols RouraChairman/CEORamon Riera RocaExec VP/Pres:Global Commercial
Alfredo Arroyo GuerraVP/CFOCarlos Roura FernandezVP/Pres:Global Industrial
More Company Profile & Key Executives for GRF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil